SPIN3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.147200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.058600E-01
Normal-vs-Stage2
1.785030E-01
Normal-vs-Stage3
8.869900E-02
Normal-vs-Stage4
7.351400E-01
Stage1-vs-Stage2
2.605000E-03
Stage1-vs-Stage3
1.517970E-02
Stage1-vs-Stage4
3.347400E-01
Stage2-vs-Stage3
9.490100E-02
Stage2-vs-Stage4
4.329600E-01
Stage3-vs-Stage4
1.702010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.554200E-01
Normal-vs-AfricanAmerican
3.499000E-01
Normal-vs-Asian
2.213200E-01
Caucasian-vs-AfricanAmerican
5.927000E-01
Caucasian-vs-Asian
6.182000E-01
AfricanAmerican-vs-Asian
8.759200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.625000E-01
Normal-vs-Female
3.846800E-01
Male-vs-Female
9.732400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.960000E-01
Normal-vs-Age(41-60Yrs)
5.099200E-01
Normal-vs-Age(61-80Yrs)
2.304000E-01
Normal-vs-Age(81-100Yrs)
3.381200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.629800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.962200E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.861960E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.409700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.971000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.155600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.749380E-01
Normal-vs-Daily Drinker
3.378400E-01
Normal-vs-Weekly Drinker
1.638220E-01
Normal-vs-Occasional Drinker
6.456400E-01
Normal-vs-Social Drinker
7.880400E-01
Non Drinker-vs-Daily Drinker
9.319600E-01
Non Drinker-vs-Weekly Drinker
7.121800E-01
Non Drinker-vs-Occasional Drinker
3.356400E-01
Non Drinker-vs-Social Drinker
2.617400E-01
Daily Drinker-vs-Weekly Drinker
7.303600E-01
Daily Drinker-vs-Occasional Drinker
4.232400E-01
Daily Drinker-vs-Social Drinker
3.045000E-01
Weekly Drinker-vs-Occasional Drinker
2.835000E-01
Weekly Drinker-vs-Social Drinker
2.040200E-01
Occasional Drinker-vs-Social Drinker
7.862000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.910610E-01
Normal-vs-Grade 2
1.128030E-02
Normal-vs-Grade 3
3.224200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.665600E-01
Grade 1-vs-Grade 3
9.188600E-01
Grade 1-vs-Grade 4
1.910610E-01
Grade 2-vs-Grade 3
1.263400E-01
Grade 2-vs-Grade 4
1.128030E-02
Grade 3-vs-Grade 4
3.224200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.274200E-02
Normal-vs-NonDiabetic
3.740600E-01
Diabetic-vs-NonDiabetic
6.685500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.118600E-01
Normal-vs-NoPancreatitis
2.849600E-01
Pancreatitis-vs-NoPancreatitis
6.315400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.932000E-01
Normal-vs-N1
1.672150E-01
N0-vs-N1
1.981380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.795600E-01
Normal-vs-TP53-NonMutant
8.045400E-01
TP53-Mutant-vs-TP53-NonMutant
8.123600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
